Wikidata

(Q39122506)

English

Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models.

scientific article published on 19 July 2013

In more languages

Statements

title
Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23873847
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23873847%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39122506&oldid=1561069253"